Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Merck
Julphar
Teva
Chubb
Dow
Citi
Deloitte
AstraZeneca
Boehringer Ingelheim

Generated: February 18, 2018

DrugPatentWatch Database Preview

REBETOL Drug Profile

« Back to Dashboard

When do Rebetol patents expire, and what generic alternatives are available?

Rebetol is a drug marketed by Merck Sharp Dohme and Schering and is included in two NDAs. There are three patents protecting this drug.

The generic ingredient in REBETOL is ribavirin. There are fifteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ribavirin profile page.
Drug patent expirations by year for REBETOL
Pharmacology for REBETOL
Medical Subject Heading (MeSH) Categories for REBETOL

US Patents and Regulatory Information for REBETOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck Sharp Dohme REBETOL ribavirin CAPSULE;ORAL 020903-001 Jun 3, 1998 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Schering REBETOL ribavirin SOLUTION;ORAL 021546-001 Jul 29, 2003 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Merck Sharp Dohme REBETOL ribavirin CAPSULE;ORAL 020903-002 Jul 25, 2001 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Merck Sharp Dohme REBETOL ribavirin CAPSULE;ORAL 020903-001 Jun 3, 1998 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Merck Sharp Dohme REBETOL ribavirin CAPSULE;ORAL 020903-002 Jul 25, 2001 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Schering REBETOL ribavirin SOLUTION;ORAL 021546-001 Jul 29, 2003 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Schering REBETOL ribavirin SOLUTION;ORAL 021546-001 Jul 29, 2003 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for REBETOL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck Sharp Dohme REBETOL ribavirin CAPSULE;ORAL 020903-001 Jun 3, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Schering REBETOL ribavirin SOLUTION;ORAL 021546-001 Jul 29, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Merck Sharp Dohme REBETOL ribavirin CAPSULE;ORAL 020903-002 Jul 25, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Merck Sharp Dohme REBETOL ribavirin CAPSULE;ORAL 020903-002 Jul 25, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Merck Sharp Dohme REBETOL ribavirin CAPSULE;ORAL 020903-002 Jul 25, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Merck Sharp Dohme REBETOL ribavirin CAPSULE;ORAL 020903-001 Jun 3, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Merck Sharp Dohme REBETOL ribavirin CAPSULE;ORAL 020903-002 Jul 25, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Schering REBETOL ribavirin SOLUTION;ORAL 021546-001 Jul 29, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Schering REBETOL ribavirin SOLUTION;ORAL 021546-001 Jul 29, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Schering REBETOL ribavirin SOLUTION;ORAL 021546-001 Jul 29, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
McKinsey
Fuji
Citi
QuintilesIMS
Teva
Healthtrust
Cipla
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot